Amyotrophic Lateral Sclerosis
Released: December 12, 2022
Department of Defense
Congressionally Directed Medical Research Programs (CDMRP)
Amyotrophic Lateral Sclerosis Research Program
Anticipated Funding Opportunities for Fiscal Year 2023 (FY23)
The FY23 Defense Appropriations Bill has not been signed into law. Although FY23 funds have not been appropriated for the Amyotrophic Lateral Sclerosis Research Program (ALSRP), the ALSRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY23 funding opportunities. This pre-announcement should not be construed as an obligation by the Government.
The FY23 Defense Appropriations Act is anticipated to provide funding for the ALSRP to support development of effective treatments for amyotrophic lateral sclerosis (ALS). The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC).
The FY23 ALSRP funding opportunity announcements for the following award mechanisms are anticipated to be posted on the Grants.gov website. Pre-application and application deadlines will be available when the announcements are released.
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Pilot Clinical Trial Award||Independent investigators at or above the level of Assistant Professor (or equivalent)||
Clinical Care Tier:
|Therapeutic Development Award||Independent investigators at all academic levels (or equivalent)||
|Clinical Biomarker Development Award||Independent investigators at all academic levels (or equivalent)||
|Therapeutic Idea Award||Independent investigators at all academic levels (or equivalent)||
A pre-application is required and must be submitted through the Biomedical Research Application Portal (eBRAP) prior to the pre-application deadline. All applications must conform to the final funding opportunity announcements that will be available for downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the funding opportunity announcements are released. For email notification when announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage. For more information about the ALSRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.health.mil).
Point of Contact:
CDMRP Public Affairs
Last updated Thursday, December 29, 2022